Cell transplantation for treatment of left-ventricular dysfunction due to ischemic heart failure: from bench to bedside

References

• Erickson H. Heart failure: a growing public health problem. J. Intern. Med.237, 135–141 (1995).
   Google Scholar
• American Heart association .2002 Statistical update. Dallas, TX: American heart association.
   Google Scholar
• Pfeffer JM, Pfeffer MA, Fltcher PF, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol.260, 1406–1414 (1991).
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med.334, 1750–1757 (2001).
   Google Scholar
• Anversa P, Nadal-ginard B. Myocyte renewal and ventricular remodeling. Nature415, 240–243 (2002).
   PubMed Web of Science ®Google Scholar
• Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N. Engl. J. Med.346, 5–15 (2002).
   PubMed Web of Science ®Google Scholar
• Chachques JC, Shafy A, Duarte F et al. From dynamic to cellular cardiomyoplasty. J. Card. Surg.17, 194–200 (2002).
   Google Scholar
• Chiu RCJ. Therapeutic cardiac angiogenesis and myogenesis: the promises and challenges on a new frontier. J. Thorac. Cardiovasc. Surg.122, 851–852 (2001).
   PubMed Web of Science ®Google Scholar
• Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cellular therapy reverses myocardial dysfunction. J. Thorac. Cardiovasc. Surg.121, 871–878 (2001).
   PubMed Web of Science ®Google Scholar
• Glaser R, Lu MM, Narula N, Epstein JA. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation106, 17–19 (2002).
   PubMed Web of Science ®Google Scholar
• Mack CA, Patel SR, Schwartz, EA et al. Biologic bypass with the use of adenovirus mediated gene transfer of the deoxyribonucleic acid for VEGF12 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg.115, 168–177 (1998).
   PubMed Web of Science ®Google Scholar
• Perin EC, Geng YJ, Willerson JT. Adult stem cell therapy in perspective. Circulation107, 935–938 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang YM, Hartzell C, Narlow M, Dudley SC Jr. Stem cell derived cardiomyocytes demonstrates arrhythmic potential. Circulation.106, 1294–1299 (2002).
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pleuripotency of mesenchymal stem cells derived from adult marrow. Nature418, 41–49 (2002).
   PubMed Web of Science ®Google Scholar
• Pagani FD, DerSimonian H, Zawadzka A et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol.41, 879–888 (2003).
   PubMed Web of Science ®Google Scholar
• Dib N, McCarthy P, Campbell A et al. Two-year follow-up of the safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Results from the United States experience. Circulation108, IV-623 (2003).
   Google Scholar
• Monnet E, Chachques JC. Animal models of heart failure: what is new? Ann Thor Surg. 79, 1445–1453 (2005).
   Google Scholar
• Swindle MM & Adams RJ. Experimental Surgery and Physiology: Induced Animal Models of human Disease. Williams & Wilkins, MD, USA (1988).
   Google Scholar
• McGoon DC. The ongoing quest for ideal myocardial protection. A catalog of the recent English literature. J. Thorac. Cardiovasc. Surg.89, 639–653 (1985).
   PubMed Web of Science ®Google Scholar
• Wallukat WG, Heschheler J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic abd cholinergic agents and Ca2+ channel blockers. Differentiation48, 173–182 (1991).
   Google Scholar
• Kawamoto A, Tkebuchava T, Yamaguchi J et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation107, 461–468 (2003).
   PubMed Web of Science ®Google Scholar
• Klug MG, Soonpaa MH, Koh GY et al. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest.98, 216–224 (1996).
   PubMed Web of Science ®Google Scholar
• Yokomuro H, Li RK, Mickle DA et al. Transplantation of cryopreserved cardiomyocytes. J. Thorac. Cardiovasc. Surg.121, 98–107 (2001).
   PubMed Web of Science ®Google Scholar
• Ott HC, Davis BH, Taylor DA..Cell therapy for heart failure – muscle, bone marrow, blood, and cardiac-derived stem cells. Semin. Thorac. Cardiovasc. Surg.17, 348–360 (2005).
   Google Scholar
• Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature410, 701–705 (2001).
   PubMed Web of Science ®Google Scholar
• Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation105, 93–98 (2002).
   PubMed Web of Science ®Google Scholar
• Perin EC, Silva GV, Sarmento-Leite R et al. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation.106, 957–961 (2002).
   PubMed Web of Science ®Google Scholar
• Perin EC, Silva GV, Leite RS. Left ventricular electromechanical mapping as a diagnostic method. In: Myocardial Revascularization: Novel Percutaneous Approaches. Abela GS (Ed.). Wiley-Liss, NY, USA183–195 (2001).
   Google Scholar
• Gepstein L. Hayam G. Shpun S. Ben-Haim SA. Hemodynamic evaluation of the heart with a nonfluoroscopic electromechanical mapping technique. Circulation.96, 3672–3680 (1997).
   PubMedGoogle Scholar
• Chachques JC. Acar C. Herreros J et al Cellular cardiomyoplasty: clinical application. Ann. Thorac. Surg..77, 1121–1130 (2004).
   PubMed Web of Science ®Google Scholar
• Miller PJ. An elastic stain. Med. Lab. Technol.28, 148–149 (1971).
   PubMedGoogle Scholar
• Herreros J, Prosper F, Perez A et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Europ. Heart J.24, 2012–2020 (2003).
   PubMed Web of Science ®Google Scholar
• Steendijk P, Smits PC, Valgimigli M, van der Giessen WJ, Onderwater EE, Serruys PW. Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure-volume loops. Nat. Clin. Pract. Cardiovasc. Med.3(Suppl. 1), S94–S100 (2006).
   PubMedGoogle Scholar
• Dohmann HF, Perin EC, Tahiya CM et al. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation.112, 521–526 (2005).
   Google Scholar
• Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation106, 1913–1918 (2002).
   PubMed Web of Science ®Google Scholar
• Tse HF, Kwong YL, Chan JK et al. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet361, 47–49 (2003).
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet.364(9429), 141–148 (year).
   Google Scholar
• Kang HJ, Kim HS, Zhang SY et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet363, 746–747 (2004).
   Google Scholar
• Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet361, 45–46 (2003).
   PubMed Web of Science ®Google Scholar
• Assmus B, Schächinger V, Teupe C et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation.106, 3009–3017 (2002).
   PubMed Web of Science ®Google Scholar
• Perin E, Dohmann HF, Borojevic R et al. Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure. Circulation.107, 2294–2302 (2003).
   PubMed Web of Science ®Google Scholar
• Epstein SE, Kornowski R, Fuchs S et al. Angiogenesis therapy. amidst the hype, the neglected potential for serious side effects. Circulation.104, 115 (2001).
   Google Scholar
• Menasche P, Desnos M. Cardiac reparation: fixing the heart with cells, new vessels and genes. Eur. Heart J.4, D73–D81 (2002).
   Google Scholar